Cerebral vasospasm
Conditions
Interventions
experimental group:Oxytocin 4IU nasal drops
Sponsors
Southern Medical University
Eligibility
Sex/Gender
Male
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients with ruptured intracranial aneurysms were admitted to hospital within 24 hours after the onset of subarachnoid hemorrhage; (2) Cerebral vasospasm was diagnosed during hospitalization, and cerebrospinal fluid and blood tests were performed; (3) Subarachnoid hemorrhage was caused by ruptured intracranial aneurysms and received endovascular interventional therapy. (4) Patients with spontaneous and non-invasive subarachnoid hemorrhage received vasospasm monitoring during lumbar puncture.
Exclusion criteria
Exclusion criteria: (1) Underlying diseases of cardiovascular, renal, respiratory, endocrine, psychiatric and neurological disorders; (2) Diagnosed with other SAH with a history of craniotomy or endoscopic surgery; (3) Receiving drugs that affect metabolism or appetite, such as clocaine, topiramate and metformin; (4) Use of antiplatelet and anticoagulant drugs or immunosuppressants within 6 months before recruitment. (or 5) cerebral vasospasm caused by improper intravascular operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebral vascular blood flow; | — |
Countries
China
Contacts
Public ContactWenfeng Feng
Southern Medical University
Outcome results
None listed